How much funding has Cytrellis Biosystems raised?

Cytrellis Biosystems has raised $78.5M in total funding, most recently a Series C round.

Who are Cytrellis Biosystems's investors?

Cytrellis Biosystems's investors include ARCH Venture Partners, D1 Capital Partners, PFM Health Sciences, Merz Venture Initiative, Partner Fund Management.

Where is Cytrellis Biosystems headquartered?

Cytrellis Biosystems is headquartered in Lexington, Massachusetts, United States.

What industry is Cytrellis Biosystems in?

Cytrellis Biosystems operates in Biotech, Healthcare.

How many employees does Cytrellis Biosystems have?

Cytrellis Biosystems has 11-50 employees.

Cytrellis Biosystems

Cytrellis, Inc. – Advancing Aesthetic Medical Technology

Lexington, United States · $78.5M raised

Biotech

Healthcare

Headquarters: Lexington, Massachusetts
Employees: 11–50
Business Model: B2B
Website: cytrellis.com

Total Funding: $78.5M
Last Round: $50.0M Series CSep 2021
Rounds: 3

About

Medical technology company developing first-in-class aesthetic devices for skin laxity treatment using microneedling technology.

Summary

Cytrellis Biosystems is a Biotech company based in Lexington, United States. It has raised $78.5M in total across 3 rounds, most recently a $50.0M Series C round in Sep 2021. Investors include ARCH Venture Partners, D1 Capital Partners and PFM Health Sciences.